In an in vitro stroke model comparison, the use of the Cover accessory device (Lazarus Effect) in conjunction with a stent retriever resulted in higher successful recanalisation rates, no embolic events and proved to be more effective than the use of a conventional guide catheter or a balloon guide catheter.
European Medical Center (GEMC) is the first institution among private clinical groups to open the clinic of neurology and neurosurgery as part of its multifunctional hospital in Moscow.
Mobile Stroke Treatment Units—specialised emergency rooms on wheels—are saving critical minutes in the diagnosis and treatment of stroke patients, according to two new studies presented at the American Stroke Association’s International Stroke Conference 2015 (Nashville, USA, 11–13 February, 2015).
One in four acute ischaemic stroke patients treated with a time-dependent clot-busting drug were quickly transferred from an emergency department or smaller community hospital to a certified stroke centre, according to research presented at the American Stroke Association’s International Stroke Conference 2015 (Nashville, USA, 11–13 February, 2015). This study will also be published simultaneously in the American Heart Association’s journal Stroke.
Drinking more than two alcoholic beverages daily in middle-age may raise your stroke risk more than traditional factors such as high blood pressure and diabetes, according to new research in the American Heart Association journal Stroke.
According to a recent retrospective review, the transradial approach to mechanical embolectomy is a valid approach for the endovascular treatment of acute ischaemic stroke.
By 2030, chronic subdural haemorrhage will be the most common adult brain condition requiring neurosurgical intervention in the USA, according to a new study conducted by researchers at NYU Langone Medical Center, USA, and hospitals and neurosurgeons may be under-manned to handle the projected onslaught of patients.
IMRIS Inc has announced that VISIUS iCT, the first and only ceiling-mounted intraoperative computed tomography scanner, has received Health Canada licensing allowing for sales and marketing in the country.
Three prominent neurosurgeons will review their clinical experience using real-time navigated laser therapy for brain lesion ablation within intraoperative MRI suites at the upcoming 83rd American Association of Neurological Surgeons (AANS) Annual Scientific Meeting (2-6 May, Washington, DC, USA). IMRIS, MRI Interventions, and Monteris Medical jointly announced that the companies are sponsoring the Lunch and Learn seminar scheduled for on Monday, 4 May.
Medtronic plc has announced that it has received clearance from the US Food and Drug Administration (FDA) for expanded indications of specific StealthStation electromagnetic surgical navigation system instruments for paediatric and adult cranial and ENT procedures.
Cefaly Technology, the creators of the first FDA-approved transcutaneous electrical nerve stimulation device specifically authorised for use prior to the onset of migraine pain, is set to announce significant breakthroughs in migraine treatment at the EUROHEADPAIN Midterm Meeting at the International Headache Society Congress in Valencia, Spain, from 14–17 May, 2015.
DUBLIN--(Healthcare Sales & Marketing Network)-- Two global trials published online in The New England Journal of Medicine (NEJM) and presented at the European Stroke Organisation Conference found that the addition of the Solitaire™ device stent thrombectomy procedure to current pharmaceutical treatment significantly reduced disability in patients suffering stroke. These trials confirmed the findings of three previous trials also published in NEJM.
Due to their unique characteristics, flow diverters were originally intended to provide a reconstructive treatment option for atypical cerebral aneurysms which previously had no feasible management alternatives, failed prior therapy, or conventional endovascular methods (coiling, stent-assisted coiling, balloon-assisted coiling, liquid embolic agents) showed suboptimal results or increased recurrence. These devices are metal mesh tubes, which on first glance may resemble conventional stents. However, significant differences are noted in that they have higher surface metal coverage and lower porosity than previously available vascular reconstruction devices.
The publication and presentation of four endovascular trials for acute ischaemic stroke has evoked a number of metaphors: “sea change”, “new day”, and “the polar vortex has lifted”. But there is an overwhelming consensus that we have taken a big step forward in acute ischaemic stroke therapy. The trial which opened the floodgates was the MR CLEAN trial (Multicentre randomized clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands) which presented its results in October at the World Stroke Congress. These clearly positive data prompted the data and safety monitoring boards of other ongoing endovascular trials to review their own data. All of these trials were then stopped early because of clear efficacy and crossing of stopping boundaries within the respective trials. And this is the reason why so many positive trials were presented simultaneously at the International Stroke Conference in Nashville, USA this February – something we may never see again at a single international stroke meeting.
In a post-hoc analysis of the use of general anaesthesia in the MR CLEAN trial (Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands) investigators have found that the subgroup of patients treated without general anaesthesia benefited more from the endovascular treatment than the subgroup treated under general anaesthesia.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos